• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CVRX, INC. BAROSTIM NEO2; IMPLANTABLE PULSE GENERATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CVRX, INC. BAROSTIM NEO2; IMPLANTABLE PULSE GENERATOR Back to Search Results
Model Number 2104
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Dizziness (2194); Implant Pain (4561)
Event Date 08/28/2023
Event Type  Injury  
Manufacturer Narrative
The results of the investigation are inconclusive at this time, and the reported device was not returned for analysis.Based on the information received, the cause of the reported event could not be conclusively determined.The device history and sterilization record for this device serial number has been reviewed.No issues or discrepancies were noted during this review that would have contributed to the reported event.The device met material, assembly, and quality control requirements.(b)(4).
 
Event Description
A barostim system was implanted on (b)(6) 2023, and therapy was left at the sub-therapeutic level of 1ma.The patient was planned to be discharged after a 12 hour observation period, however, the patient was still inpatient on (b)(6) 2023.It was noted the patient had complained of surgical site pain, and oxycodone was administered.It was unknown why the patient was not given tylenol and discharged.The patient was still inpatient on (b)(6) 2023, and complained of pain.It was reported that oxycodone had been administered to the patient multiple times and the patient was somnolent.Pain medications were discontinued (b)(6) 2023 on the direction of the physician to discharge the patient.As of (b)(6) 2023, the patient was still inpatient and complaining of surgical site pain.Later that day, the patient reported to be dizzy and barostim therapy was turned off.It was noted that there were no notes in the patient's chart that they experienced pain or dizziness, but the patient stated they experienced pain starting at the pocket site going up to their neck.The managing physician was unable to determine the root cause of the dizziness.As of the evening of (b)(6) 2023, the patient stated the pain had subsided.The patient was discharged over the weekend of (b)(6) 2023.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BAROSTIM NEO2
Type of Device
IMPLANTABLE PULSE GENERATOR
Manufacturer (Section D)
CVRX, INC.
9201 west broadway avenue
suite 650
minneapolis 55445
Manufacturer (Section G)
CVRX, INC.
9201 west broadway avenue
suite 650
minneapolis 55445
Manufacturer Contact
sarah hicks
9201 west broadway avenue
suite 650
minneapolis 55445
MDR Report Key17797893
MDR Text Key324018587
Report Number3007972010-2023-00046
Device Sequence Number1
Product Code DSR
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P180050
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 09/22/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/22/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Model Number2104
Device Catalogue Number100065-202
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received08/31/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/18/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
Patient Age71 YR
Patient SexFemale
-
-